🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

19 recruiting trials

for Severe Tricuspid Regurgitation

A Study to Evaluate the Safety and Performance of TruGamma System for Tricuspid Replacement NCT07691307NA1 site📍 Beijing Jiangsu Trulive Medical Co., Ltd · Tests: TruGamma System, Optimal medical therapy (OMT) Characteristics and Prognosis of Moderate or Severe Tricuspid Regurgitation NCT03546231n/a1 site📍 Amiens Centre Hospitalier Universitaire, Amiens Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS) NCT06212193NA12 sites📍 Thousand Oaks📍 Detroit📍 Rochester Innoventric LTD · Tests: Trillium™ Safety and Feasibility Study: Transcatheter Valve Repair in Severe Symptomatic Functional Tricuspid Regurgitation NCT07140562NA1 site📍 Asunción Tangent Cardiovascular Inc. · Tests: Tricuspid Annular Therapy System Pivotal Trial to Evaluate TraNsvenous TrIcuspid Valve ReplacemenT With LuX-Valve Plus System (The TRINITY Pivotal Trial) NCT07454980NA7 sites📍 Naples📍 The Bronx📍 Vancouver Jenscare Innovation Inc. · Tests: TTVI with LuX-Valve Plus System, TTVI with EVOQUE Safety and Effectiveness Study of DragonFly-T System for Severe Tricuspid Regurgitation NCT05556460NA2 sites📍 Chengdu📍 Hangzhou Hangzhou Valgen Medtech Co., Ltd · Tests: DragonFly-T Transcatheter Tricuspid Valve Repair System, Medical therapy Patients With Severe TrIcuspid Regurgitation After triCvALve System Implantation NCT05820516n/a1 site📍 Pisa Azienda Ospedaliero, Universitaria Pisana · Tests: TricValve implantation International Multisite Transcatheter Tricuspid Valve Therapies Registry NCT03416166n/a1 site📍 Zurich University of Zurich · Tests: Transcatheter Tricuspid Intervention A Prospective, Multicenter, Randomized Controlled Clinical Trial of Transcatheter Tricuspid Valve Clipping Systems. NCT07433504NA1 site📍 Shanghai Shanghai Huihe Medical Technology Co., Ltd · Tests: Experimental: Transcatheter tricuspid valve repair using the transcatheter tricuspid valve clipping system +GDMT, Guide… Evaluation of the Impact of Interventional Treatments for Symptomatic, Severe Tricuspid Valve Insufficiency on Renal Integrity and Function, as Well as on Physical Function and Activity in Older Adults. NCT07464106n/a1 site📍 Stuttgart Robert Bosch Medical Center · Tests: Transcatheter edge-to-edge repair (TEER) Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation NCT07321899NA13 sites📍 Birmingham📍 Phoenix📍 Thousand Oaks Medtronic Cardiovascular · Tests: Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System, Edwards EVOQUE Tricuspid Valve Replacement… ChAracterization of Patients and Treatment OUtcomes in Severe Tricuspid Regurgitation NCT06838611n/a1 site📍 Warsaw Medical University of Warsaw · Tests: Transcatheter edge-to-edge repair Retrospective Prospective Multicentric Clinical Follow up of Patients After Being Treated With TricValve® NCT05114850n/a28 sites📍 Sankt Pölten📍 Vienna📍 Vienna P+F Products + Features GmbH VDyne Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial) NCT07516444NA1 site📍 Minneapolis VDyne, Inc. · Tests: Transcatheter Tricuspid Valve Replacement (TTVR) with VDyne System, Transcatheter Tricuspid Valve Replacement (TTVR) wi… TRICuspid Intervention and Invasive Hemodynamic Monitoring in Heart Failure NCT07442903NA2 sites📍 Munich📍 München LMU Klinikum · Tests: Pulmonary artery sensor system First-in-man Trial to Assess the Safety, Performance and Clinical Benefit of the TRICENTO G2 Transcatheter Valve System for Tricuspid Regurgitation NCT07536724NA2 sites📍 Tashkent📍 Tashkent Medira GmbH · Tests: TRICENTOG2 Transcatheter Valve System for Tricuspid Regurgitation (TRICENTOG2 TVSTR) Influence of Lung Ultrasonography on the Prognosis and Postoperative Outcomes in Cardiac Surgical Patients NCT06377449NA1 site📍 Saint Petersburg Saint Petersburg State University, Russia · Tests: Ultrasound examination of the lungs TTVR STRONG Under Coverage With Evidence Development (CED) Study NCT06833476n/a1 site📍 Irvine Edwards Lifesciences · Tests: EVOQUE Annuloplasty for Not-Severe TR in Patients Undergoing MV Repair Versus Mitral Repair Only (NOSTRUM) NCT02996552NA3 sites📍 Rozzano📍 Milan📍 Warsaw Ospedale San Raffaele · Tests: M & T Repair Group, Mitral-Only Group
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy